The antibacterial and antibiofilm role of cannabidiol against periodontopathogenic bacteria
Journal of Applied Microbiology · 2025
DOI: 10.1093/jambio/lxae316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2025. Verfasst von Anna Livia Oliveira Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia, MG 38405-32…. Hauptthemen laut MEDLINE: Biofilms, Cannabidiol, Anti-Bacterial Agents, Periodontitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministry of Education, Brazil, Brazilian Company of Research and Industrial Innovation.
Abstract (Originalsprache)
Aims
Bacterial resistance and systemic risks associated with periodontitis underscore the need for novel antimicrobial agents. Cannabis sativa is a promising source of antimicrobial molecules, and cannabidiol (CBD) attracts significant interest. This study evaluated the antibacterial and antibiofilm activity of CBD against periodontopathogens, and assessed its toxicity in vivo model. Methods and results Antibacterial activity was determined by the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Biofilm inhibition was determined the minimum inhibitory concentration of biofilm (MICB50). Toxicity was assessed using Caeonorhabditis elegans. The periodontopathogens tested were Actinomyces naeslundii (ATCC 19039), Peptostreptococcus anaerobius (ATCC 27337), Veillonella parvula (ATCC 17745), Fusobacterium nucleatum (ATCC 10953), and Aggregatibacter actinomycetemcomitans (ATCC 43717). CBD exhibited antibacterial effects with MICs of 0.39 to 3.12 µg ml−1 and MICB50 of 0.39 µg ml−1 to 1.56 µg ml−1 against biofilms, without toxicity below 375 µg ml−1.
Conclusion
The results suggest that CBD is a non-toxic product with antibacterial and antibiofilm potential, exhibiting promise as a therapeutic alternative for oral diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia, MG 38405-320, Brazil.
- Laboratory of Vegetable Cultivation (LCV), Campus Centro-Oeste Dona Lindu, Federal University of São João del Rei, Divinópolis, MG 35501-296, Brazil.
ORCID-Profile: Carlos Henrique Gomes Martins
Förderung
- Ministry of Education, Brazil
- Brazilian Company of Research and Industrial Innovation
Zitieren
APA
Santos, A. L. O., Santiago, M. B., Silva, N. B. S., Souza, S. L., Almeida, J. M. D., & Martins, C. H. G. (2025). The antibacterial and antibiofilm role of cannabidiol against periodontopathogenic bacteria. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae316
Vancouver
Santos ALO, Santiago MB, Silva NBS, Souza SL, Almeida JMD, Martins CHG. The antibacterial and antibiofilm role of cannabidiol against periodontopathogenic bacteria. Journal of Applied Microbiology. 2025. doi:10.1093/jambio/lxae316
BibTeX
@article{Santos2025,
author = {Santos, Anna Livia Oliveira and Santiago, Mariana Brentini and Silva, Nagela Bernadelli Sousa and Souza, Sara Lemes and Almeida, Joaquim Maurício Duarte and Martins, Carlos Henrique Gomes},
title = {The antibacterial and antibiofilm role of cannabidiol against periodontopathogenic bacteria},
journal = {Journal of Applied Microbiology},
year = {2025},
doi = {10.1093/jambio/lxae316}
}
EUVIMED